Technical Data
E3440-10K
Epstein Barr Virus, Early Antigen Diffuse (EBV EAD, Human Herpes virus 4, HHV4)
Description:
Epstein Barr virus early antigens are non-structural pro- teins that do not require viral DNA replication for synthesis. This antibody detects early antigen diffuse during the lytic phase of virus replication.

Applications:
Suitable for use in Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 1:250-1:500
Optimal dilutions to be determined by the researcher.

Positive Control:
B95-8 cell line

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG1G3-E31Supernatant
SizeStorageShippingSourceHost
1ml-20CBlue IceMouse
Concentration:
Not determined
Immunogen:
B95-8 cell lysates treated with phorbol myristic acid (PMA).
Purity:
Supernatant
Form
Supplied as a lyophilized powder in 15mM sodium azide. Reconstitute with 1ml dH2O.
Specificity:
Recognizes EAD.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1.Thomas J A, Felix D H, Wray D, et al.. Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. American Journal of Pathology. 139(6):1369-1380 (1991). 2.Miller G. Epstein-Barr Virus-Biology, pathogenesis, and medical aspects. Virology, Second Edition. 1921-1958 (1990).